NCT00654784View on ClinicalTrials.gov

Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Duchenne Muscular Dystrophy (DMD)
Interventions
DRUG

idebenone

idebenone 450 mg/day (150 mg three times a day)

DRUG

placebo

Trial Locations (1)

Unknown

Children's Hospital, University Hospital, Leuven

Sponsors
All Listed Sponsors
lead

Santhera Pharmaceuticals

INDUSTRY